Health and Fitness Health and Fitness
Wed, April 25, 2012
Tue, April 24, 2012
Mon, April 23, 2012
Sun, April 22, 2012
Sat, April 21, 2012
Fri, April 20, 2012
Thu, April 19, 2012
Wed, April 18, 2012
Tue, April 17, 2012
Mon, April 16, 2012
Sun, April 15, 2012
[ Sun, Apr 15th 2012 ] - Market Wire
DaVita Announces CFO Transition
Sat, April 14, 2012
Fri, April 13, 2012
Thu, April 12, 2012
Wed, April 11, 2012

Synta to Host First-Quarter 2012 Conference Call on May 3, 2012


//health-fitness.news-articles.net/content/2012/ .. -quarter-2012-conference-call-on-may-3-2012.html
Published in Health and Fitness on Thursday, April 19th 2012 at 5:20 GMT by Market Wire   Print publication without navigation


LEXINGTON, Mass.--([ ])--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that it will release its first-quarter 2012 financial results before the market opens on Thursday, May 3, 2012.

Management will conduct a conference call at 10:00 a.m. (ET) that morning to review the Company's first-quarter financial results. The conference call will be webcast live over the Internet and can be accessed by logging on to the "Investors" section of the Synta Pharmaceuticals website, [ www.syntapharma.com ], prior to the event.

The call also can be accessed by dialing (877) 407-8035 or (201) 689-8035 prior to the start of the call. For those unable to join the live conference call, a replay will be available from 2:00 p.m. (ET) on May 3 through midnight (ET) on May 10. To access the replay, dial (877) 660-6853 or (201) 612-7415 and refer to both account number 286 and conference ID 392603. The webcast also will be archived on the Company's website.

About Synta Pharmaceuticals

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. For more information, please visit [ www.syntapharma.com ].


Publication Contributing Sources